Tofacitnib for the Treatment of Alopecia Areata and Variants

Exclusion Criteria

• •Age \<18 years old
• •Patients have received treatment known to affect alopecia areata within 2 months of enrolling in the study
• •Patients with a history of malignancy (except history of successfully treated basal cell or squamous cell carcinoma of the skin)
• •Patients known to be HIV or hepatitis B or C positive
• •Patients with positive tuberculin skin test or positive QuantiFERON TB test
• •Patients with leukopenia or anemia
• •Patients with renal or hepatic impairment
• •Patients with peptic ulcer disease
• •Patients taking immunosuppressive medications, including but not limited to prednisone, methotrexate, mycophenolate mofetil, azathioprine, tacrolimus, cyclosporine, or TNH-alpha inhibitors
• •Women of childbearing potential who are unable or unwilling to use birth control while taking the medication
• •Women who are pregnant or nursing